Related Experiment Video
Updated: Jan 10, 2026

Automated, Long-term Behavioral Assay for Cognitive Functions in Multiple Genetic Models of Alzheimer's Disease, Using IntelliCage
Published on: August 4, 2018
ADAS-Cog Trajectories Differ from Expected Decline in Dementia Following Repeated Non-Invasive Interventions over 3
Maria Anabel Uehara1, Sumeet Kalia2, Mari Garcia Campuzano3
1Biomedical Engineering, University of Manitoba, Winnipeg, MB R3T 5V6, Canada.
Repeated non-invasive treatments like cognitive training and brain stimulation significantly slowed cognitive decline in Alzheimer's disease (AD) patients over 1-3 years. Longer breaks between treatments worsened decline, suggesting sustained interventions are key for dementia management.
Area of Science:
- Neuroscience
- Gerontology
- Clinical Neurology
Background:
- Non-pharmaceutical interventions, including cognitive training, transcranial electrical stimulation (tES), and repetitive transcranial magnetic stimulation (rTMS), show potential for improving cognitive function in Alzheimer's disease (AD) and dementia.
- The long-term efficacy and impact of repeated non-invasive interventions on cognitive trajectories in dementia patients remain largely unknown.
- This study addresses the need to understand the sustained effects of these interventions over extended periods.
Purpose of the Study:
- To investigate if repeated non-invasive interventions administered over 1 to 3 years are associated with slower cognitive decline compared to typical Alzheimer's disease progression.
- To determine if longer intervals without treatment predict greater cognitive decline after intervention periods.
- To evaluate the long-term effectiveness of non-pharmaceutical interventions in managing cognitive decline in dementia.
Main Methods:
- Seventy-three participants with dementia or AD underwent 2 to 9 blocks of non-invasive treatments (tES, rTMS, cognitive training).
- Cognitive decline was tracked longitudinally using Alzheimer's Disease Assessment Scale-Cognitive subscale (ADAS-Cog) scores for up to 36 months.
- Mixed-effects models were used to compare the observed rate of cognitive decline to established AD progression rates, adjusting for baseline factors.
Main Results:
- Participants exhibited a significantly slower rate of cognitive decline than the reference AD progression rate (p < 0.001).
- Many participants maintained stable ADAS-Cog scores during treatment periods lasting 1 to 3 years.
- Longer no-treatment intervals were significantly linked to increased post-treatment cognitive decline (p < 0.001), while AD medications showed no significant impact.
Conclusions:
- Repeated non-invasive interventions, when applied consistently over extended periods, appear to mitigate cognitive decline in individuals with dementia.
- The findings support the feasibility and effectiveness of personalized, long-term non-invasive treatment strategies for managing dementia.
- Sustained intervention delivery is crucial, as extended breaks correlate with accelerated cognitive decline.
Related Concept Videos
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Cognitive Development During Adulthood
Alzheimer's Disease: Treatment
Longitudinal Research

